indiavisioninstitute
Skip to Content
 

Upcoming Programs


Call for Abstracts: 3rd IVI International Optometry Conference - Eye Health in a Changing World, powered by Essilor Stellest

indiavisioninstitute


3rd IVI International Optometry Conference - Eye Health in a Changing World

13 - 15 October 2022


GUIDELINES FOR ABSTRACT SUBMISSION

The scientific program committee welcomes you to participate in IVI's 3rd International Optometry Conference - Eye Health in a Changing World (EHCW), by submitting abstracts for oral and poster presentations under 20 categories as listed below: 

  1. Assessment of Visual Functions

  2. Contact lens 

  3. Case reports 

  4. Digital Health and Technology
  5. Evidence Based Practice

  6. Geriatric Vision

  7. Low Vision and Rehabilitation

  8. Myopia Management

  9. Occupational Vision

  10. Ocular Diagnostics

  11. Optics

  12. Optometry Education

  13. Optometry Innovations/Advancements

  14. Pediatric Optometry & Binocular Vision

  15. People Centered Eyecare/Public Eye Health

  16. Pre & Post Operative Assessments and Complications

  17. Refractive Error Management 

  18. Spectacle - Dispensing Trends

  19. Systemic and Ocular Diseases

  20. Others

If you have any questions or difficulty with the online abstract submission process, please contact [email protected]

Deadline, Review and Acceptance 

Online submissions of abstracts are due by Monday, 05 September 2022 at 23:59 hours IST. Submissions will be reviewed by the EHCW Scientific Committee and primary authors will be notified if the abstract has been accepted or declined by Saturday, 17 September 2022.

Best ONE poster presentation and oral presentation under EACH CATEGORY will be given awards

General Submission Guidelines

Please read through the guidelines before filling up the abstract submission form. 

  1. A submission has to be in English and must be submitted using the application form on the website. 

Application Form : https://forms.gle/r3EeLTZ29voF27xm9



  1. The abstract submitted should purely be the author’s work and plagiarism is not accepted.

 

  1. Please ensure contact details are entered correctly to avoid delays in communicating our decisions with you. 


  1. First author is permitted for a maximum of two presentations (one oral presentation and one poster presentation) within the scientific program. There is no limit to the number of co-authored submissions, e.g. authors may be listed as second, third or other position on any number of submissions.


  1. The first author is solely responsible for presentation of accepted abstracts at the date and time assigned by the Scientific Program Committee. Co-authors, substitutes, or multiple presenters are not permitted. 


  1. First authors will be scheduled for oral presentations between 1.30 pm to 5.30 pm (IST) on Friday, 14 October or between 1.30 pm to 5.30 pm (IST) on Saturday, 15 October 2022. Please do not submit to the scientific program unless you can commit to be present when assigned.


  1. Abstracts can be submitted either for an oral (paper) or poster presentation. Multiple entries are not encouraged. However, the review committee has the freedom to select your submission for poster presentation in case of rejection in the oral presentation category. Choose Oral/Poster presentation option in the application form if you would like your abstracts to be included in either of the two categories.


  1. Abstracts can be submitted under any one of the 19 categories which will appear as a drop-down list in the online abstract submission form. If you have a conflict in choosing the stream or your topic does not align with the list, you may opt for the ‘OTHERS’ category.  


  1. Abstract body should include purpose, methodology, results and conclusion. The character count should not exceed 3,000 including spaces.


  1. *Financial and Conflict of Interest Disclosure: The first author is responsible for disclosing any financial and/or conflict of interest on behalf of all listed authors as defined below. Any conflict of interest must also be disclosed at the time of presentation; this applies to both scientific paper and poster presentations. Contact [email protected] for any queries.


*A conflict of interest exists if financial interests or other opportunities for tangible personal benefit may exert a substantial and improper influence on a researcher's professional judgment in designing, conducting, or reporting research. A conflict of interest is not an accusation and does not imply that a researcher's judgment has been compromised. The following types of situations describe conflicts of interest that should be disclosed in your presentation.


  1. Please ensure work has not been published or previously presented at a major meeting as part of the submission process.

12. Ethical and Regulatory Requirements for Research and Case Reports:

Research involving human subjects must have been conducted in accordance with the tenets of the Declaration of Helsinki and with adherence to any applicable national and local human subjects research requirements. Consistent with the National Institutes of Health guidelines, if the number of human subjects in the study exceeds three, Institutional Review Board (IRB) approval must be obtained. The authors cannot automatically assume that certain studies are exempt from IRB review. Only an IRB can determine if a specific study fulfills the exempt status.

Research involving the use of animals must be conducted in accordance with international standards for animal treatment and care (e.g., the Society of Neurosciences and ARVO statements on the use of animals in research) as well as any applicable regulatory requirements. If the work submitted involves the use of animals, Institutional Animal Care and Use Committee (IACUC) approval must have been obtained.

Failure to conform to the above ethical standards may result in loss of privileges for all listed authors to submit abstracts or proposals to subsequent meetings.

13. Author Agreements 

By submitting an abstract, the author confirms and agrees to the following: 

1. The author/s approves submitting this work for 3rd IVI International Optometry Conference - Eye Health in a Changing World (EHCW), 13 - 15 October 2022. 
2. The author/s have done the work reported in the abstract and take full responsibility for the contents. 
3. The author/s agrees to confine their presentation to the topic in the abstract. 
4. The presenting author will notify the EHCW Scientific Committee if he / she is unable to make a presentation or if the presenting author must be changed. 
5. If an individual replaces the presenting author, that individual may not be the presenting author of another submitted abstract. 
6. The author is responsible for using correct grammar and spelling but the Scientific Committee reserves the right to edit abstracts for grammar and spelling. 
7. The author/s approve that the content submitted is not subject to copyright restrictions arising from pre-existing copyright agreements or transfer. 

8. Applications failing to confirm the above would be considered incomplete and not eligible for review.


14. Abstracts will be reviewed for their structure, content, perceived value to EHCW Delegates and degree of innovation. All decisions are final. 

15. Selected papers for an oral presentation will be given 10 minutes to present, along with 5 minutes for Q&A and posters will be given 3 minutes to present. Poster presentations will be recorded and uploaded in the virtual conference platform. Selected paper presentations will be presented at the venue.

17. First authors of selected papers and posters will be notified through email about the presentation requirement by the conference team. 

18. First authors of selected abstracts are eligible for 50% off on the registration fee (First authors of selected papers - 50% off on online and on-site registration fee; First authors of selected posters - 50% off on online registration fee). A refund will be initiated if the author has already registered for the conference.